Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryFDA-cleared echocardiography AI that analyzes apical four-chamber clips to support detection of heart failure with preserved ejection fraction.
Heart-failure and echo programs evaluating structured AI support for HFpEF workups in clinician-reviewed workflows.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Ultromics EchoGo as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Match the EchoGo Heart Failure version, 510(k) record, indication, product code, geography, and reimbursement workflow before using output in a heart-failure pathway. |
|---|---|
| Privacy | Review echocardiography upload flow, cloud or integration partner processing, customer-controller obligations, retention, deletion, access controls, DPO contact path, and support-data handling. |
| Evidence | Evaluate HFpEF detection evidence, eligible echo views, image-quality failures, false-positive and false-negative burden, patient population fit, and downstream testing or referral impact. |
| Workflow | Best governed as cardiologist-reviewed echo decision support that feeds HFpEF diagnostic workups, structured reporting, and follow-up planning rather than autonomous diagnosis. |
Ultromics describes EchoGo Heart Failure as an FDA-cleared AI-enabled medical device and diagnostic aid for HFpEF detection from echocardiography; FDA records list EchoGo Heart Failure 510(k) clearances, and Ultromics privacy materials describe customer-controlled patient-data processing and EchoGo retention terms.
Not for: Standalone heart-failure diagnosis, unsupported echo views, or use outside the cleared indication, product version, and physician-review workflow.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.